Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Autosomal recessive atrial dilated cardiomyopathy with standstill evolution associated with mutation of Natriuretic Peptide Precursor A.

Disertori M, Quintarelli S, Grasso M, Pilotto A, Narula N, Favalli V, Canclini C, Diegoli M, Mazzola S, Marini M, Del Greco M, Bonmassari R, Masè M, Ravelli F, Specchia C, Arbustini E.

Circ Cardiovasc Genet. 2013 Feb;6(1):27-36. doi: 10.1161/CIRCGENETICS.112.963520. Epub 2012 Dec 29.

2.

Atrial cardiomyopathy an orphan disease or common disorder?

Fatkin D, Nikolova-Krstevski V.

Circ Cardiovasc Genet. 2013 Feb;6(1):5-6. doi: 10.1161/CIRCGENETICS.111.000033. No abstract available.

3.
4.

Compound heterozygous mutations in the SCN5A-encoded Nav1.5 cardiac sodium channel resulting in atrial standstill and His-Purkinje system disease.

Baskar S, Ackerman MJ, Clements D, Mayuga KA, Aziz PF.

J Pediatr. 2014 Nov;165(5):1050-2. doi: 10.1016/j.jpeds.2014.07.036. Epub 2014 Aug 27.

PMID:
25171853
5.
6.

Familial atrial standstill in association with dilated cardiomyopathy.

Fazelifar AF, Arya A, Haghjoo M, Sadr-Ameli MA.

Pacing Clin Electrophysiol. 2005 Sep;28(9):1005-8.

PMID:
16176547
7.

Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features.

Bhuiyan ZA, van den Berg MP, van Tintelen JP, Bink-Boelkens MT, Wiesfeld AC, Alders M, Postma AV, van Langen I, Mannens MM, Wilde AA.

Circulation. 2007 Oct 2;116(14):1569-76. Epub 2007 Sep 17.

8.

Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.

Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J, Vidaillet HJ Jr, Spudich S, De Girolami U, Seidman JG, Seidman C, Muntoni F, Müehle G, Johnson W, McDonough B.

N Engl J Med. 1999 Dec 2;341(23):1715-24.

9.

Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: endocrinologic silence.

Seino Y, Shimai S, Ibuki C, Itoh K, Takano T, Hayakawa H.

J Am Coll Cardiol. 1991 Aug;18(2):459-63.

10.

Isolated left atrial standstill identified during catheter ablation.

Duncan E, Schilling RJ, Earley M.

Pacing Clin Electrophysiol. 2013 Apr;36(4):e120-4. doi: 10.1111/j.1540-8159.2010.02957.x. Epub 2010 Nov 11.

PMID:
21070263
11.

Serum atrial natriuretic peptide concentration is a useful predictor of atrial standstill in patients with heart failure.

Suguta M, Hara K, Nakano A, Amano A, Hasegawa A, Kurabayashi M.

Jpn Circ J. 2000 Jul;64(7):537-40.

12.

High incidence of sudden cardiac death with conduction disturbances and atrial cardiomyopathy caused by a nonsense mutation in the STA gene.

Sakata K, Shimizu M, Ino H, Yamaguchi M, Terai H, Fujino N, Hayashi K, Kaneda T, Inoue M, Oda Y, Fujita T, Kaku B, Kanaya H, Mabuchi H.

Circulation. 2005 Jun 28;111(25):3352-8. Epub 2005 Jun 20.

13.

Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.

van Rijsingen IA, Bakker A, Azim D, Hermans-van Ast JF, van der Kooi AJ, van Tintelen JP, van den Berg MP, Christiaans I, Lekanne Dit Deprez RH, Wilde AA, Zwinderman AH, Meijers JC, Grootemaat AE, Nieuwland R, Pinto YM, Pinto-Sietsma SJ.

Int J Cardiol. 2013 Sep 20;168(1):472-7. doi: 10.1016/j.ijcard.2012.09.118. Epub 2012 Oct 14.

14.

A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding.

van de Meerakker JB, Christiaans I, Barnett P, Lekanne Deprez RH, Ilgun A, Mook OR, Mannens MM, Lam J, Wilde AA, Moorman AF, Postma AV.

Biochim Biophys Acta. 2013 Apr;1833(4):833-9. doi: 10.1016/j.bbamcr.2012.11.003. Epub 2012 Nov 9.

15.

Renal dysfunction is a confounder for plasma natriuretic peptides in detecting heart dysfunction in uremic and idiopathic dilated cardiomyopathies.

Codognotto M, Piccoli A, Zaninotto M, Mion M, Plebani M, Vertolli U, Tona F, Ruzza L, Barchita A, Boffa GM.

Clin Chem. 2007 Dec;53(12):2097-104. Epub 2007 Oct 12.

16.

Identification of a new lamin A/C mutation in a Chinese family affected with atrioventricular block as the prominent phenotype.

Wu X, Wang QK, Gui L, Liu M, Zhang X, Jin R, Li W, Yan L, Du R, Wang Q, Zhu J, Yang J.

J Huazhong Univ Sci Technolog Med Sci. 2010 Feb;30(1):103-7. doi: 10.1007/s11596-010-0119-z. Epub 2010 Feb 14.

PMID:
20155465
17.

Plasma atrial natriuretic peptide is elevated in patients with hypertrophic cardiomyopathy.

Fahy GJ, McCreery CJ, O'Sullivan F, Keenan AK, Quigley PJ, Maurer BJ.

Int J Cardiol. 1996 Jul 26;55(2):149-55.

PMID:
8842784
18.

Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy.

Theis JL, Sharpe KM, Matsumoto ME, Chai HS, Nair AA, Theis JD, de Andrade M, Wieben ED, Michels VV, Olson TM.

Circ Cardiovasc Genet. 2011 Dec;4(6):585-94. doi: 10.1161/CIRCGENETICS.111.961052. Epub 2011 Sep 30.

19.

Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.

Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.

Rev Port Cardiol. 2004 Dec;23(12):1557-82. English, Portuguese.

PMID:
15732658
20.

Long-term outcome and risk stratification in dilated cardiolaminopathies.

Pasotti M, Klersy C, Pilotto A, Marziliano N, Rapezzi C, Serio A, Mannarino S, Gambarin F, Favalli V, Grasso M, Agozzino M, Campana C, Gavazzi A, Febo O, Marini M, Landolina M, Mortara A, Piccolo G, Viganò M, Tavazzi L, Arbustini E.

J Am Coll Cardiol. 2008 Oct 7;52(15):1250-60. doi: 10.1016/j.jacc.2008.06.044.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk